Member News
-
Coeptis Therapeutics’ Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy
October 15, 2024 (Source) — Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the “Company” or “Coeptis”), a biopharmaceutical company developing…
-
Defense Metals Announces Closing of Fully Subscribed Convertible Bridge Financing; Raises Gross Proceeds of $4 Million & Provides Update on Prefeasibility Study and CEO Search
October 11, 2024 (Source) — Defense Metals Corp. (“Defense Metals” or the “Company”) (TSXV: DEFN) (OTCQB: DFMTF) (FSE: 35D)…
-
F3 Announces Revised Bought Deal Private Placement for Gross Proceeds of C$7 Million
October 10, 2024 (Source) — F3 Uranium Corp. (TSXV: FUU) (OTC Pink: FUUFF) (“F3 Uranium” or the “Company”) is…
-
Enoch Cree Nation and Sol Spaces Inc. Forge Transformative Partnership to Cultivate Sustainable Food Security
October 10, 2024 (Source) — Visionstate Corp. Is pleased to announce its portfolio company, Sol Spaces Inc., an…
-
F3 Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
October 9, 2024 (Source) — F3 Uranium Corp. (TSXV: FUU) (OTC: FUUFF) (“F3 Uranium” or the “Company”) is pleased…
-
Visionstate Ramps Up Expansion Plans
October 9, 2024 (Source) — Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), is pleased to announce several key developments…
